Kyverna Therapeutics, Inc.KYTXNASDAQ
Loading
Revenue Growth TrendStable
Percentile Rank9
Studio
Year-over-Year Change

Year-over-year revenue growth rate

Latest
0.00%
↑ 100% vs avg
Percentile
P9
Near historical low
Average
-8.33%
Historical baseline
PeriodValue
Q3 20250.00%
Q2 20250.00%
Q1 20250.00%
Q4 20240.00%
Q3 20240.00%
Q2 20240.00%
Q1 20240.00%
Q4 20230.00%
Q3 20230.00%
Q2 20230.00%
Q1 2023-100.00%
Q4 20220.00%